EUVIMEDEUVIMED entdecken
Systematische Übersicht

Association Between Single-Dose and Longer Term Clinical Response to Stimulants in Attention-Deficit/Hyperactivity Disorder: A Systematic Review of Randomized Controlled Trials

Valeria Parlatini iD, Alessio Bellato, Sulagna Roy, Declan Murphy, Samuele Cortese

Journal of Child and Adolescent Psychopharmacology · 2024

DOI: 10.1089/cap.2024.0038 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, 2024. Verfasst von Valeria Parlatini und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Psychology, University of Southampton, Southampton, United Kingdom. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Central Nervous System Stimulants, Methylphenidate. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 85 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Stimulants, such as methylphenidate (MPH) and amphetamines, represent the first-line pharmacological option for attention-deficit/hyperactivity disorder (ADHD). Randomized controlled trials (RCTs) have demonstrated beneficial effects at a group level but could not identify characteristics consistently associated with varying individual response. Thus, more individualized approaches are needed. Experimental studies have suggested that the neurobiological response to a single dose is indicative of longer term response. It is unclear whether this also applies to clinical measures.

Methods

We carried out a systematic review of RCTs testing the association between the clinical response to a single dose of stimulants and longer term improvement. Potentially suitable single-dose RCTs were identified from the MED-ADHD data set, the European ADHD Guidelines Group RCT Data set (https://med-adhd.org/), as updated on February 1, 2024. Quality assessment was carried out using the Cochrane Risk of Bias (RoB) 2.0 tool.

Results

A total of 63 single-dose RCTs (94% testing MPH, 85% in children) were identified. Among these, only a secondary analysis of an RCT tested the association between acute and longer term clinical response. This showed that the clinical improvement after a single dose of MPH was significantly associated with symptom improvement after a 4-week MPH treatment in 46 children (89% males) with ADHD. The risk of bias was rated as moderate. A further RCT used near-infrared spectroscopy, thus did not meet the inclusion criteria, and reported an association between brain changes under a single-dose and longer term clinical response in 22 children (82% males) with ADHD. The remaining RCTs only reported single-dose effects on neuropsychological, neuroimaging, or neurophysiological measures.

Conclusion

This systematic review highlighted an important gap in the current knowledge. Investigating how acute and long-term response may be related can foster our understanding of stimulant mechanism of action and help develop stratification approaches for more tailored treatment strategies. Future studies need to investigate potential age- and sex-related differences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Attention Deficit Disorder with HyperactivityCentral Nervous System StimulantsMethylphenidateChildHumansMaleDose-Response Relationship, DrugRandomized Controlled Trials as TopicTreatment OutcomeFemale

Stichwörter der Autor:innen

attention-deficit/hyperactivity disorder (ADHD)methylphenidate (MPH)randomized controlled trials (RCTs)single dosestimulanttreatment response

Substanzen

Central Nervous System StimulantsMethylphenidate

Autor:innen und Institutionen

  • School of Psychology, University of Southampton, Southampton, United Kingdom.
  • Centre for Innovation in Mental Health, University of Southampton, Southampton, United Kingdom.
  • Institute for Life Sciences, University of Southampton, Southampton, United Kingdom.
  • Institute of Translational Neurodevelopment, Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Solent NHS Trust, Southampton, United Kingdom.

ORCID-Profile: Valeria Parlatini

Zitieren

APA

Parlatini, V., Bellato, A., Roy, S., Murphy, D., & Cortese, S. (2024). Association Between Single-Dose and Longer Term Clinical Response to Stimulants in Attention-Deficit/Hyperactivity Disorder: A Systematic Review of Randomized Controlled Trials. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2024.0038

Vancouver

Parlatini V, Bellato A, Roy S, Murphy D, Cortese S. Association Between Single-Dose and Longer Term Clinical Response to Stimulants in Attention-Deficit/Hyperactivity Disorder: A Systematic Review of Randomized Controlled Trials. Journal of Child and Adolescent Psychopharmacology. 2024. doi:10.1089/cap.2024.0038

BibTeX
@article{Parlatini2024,
  author = {Parlatini, Valeria and Bellato, Alessio and Roy, Sulagna and Murphy, Declan and Cortese, Samuele},
  title = {Association Between Single-Dose and Longer Term Clinical Response to Stimulants in Attention-Deficit/Hyperactivity Disorder: A Systematic Review of Randomized Controlled Trials},
  journal = {Journal of Child and Adolescent Psychopharmacology},
  year = {2024},
  doi = {10.1089/cap.2024.0038}
}
Kostenlos starten →